Synergistic activation of cardiac genes by myocardin and Tbx5

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Wang, Chunbo ^b,c   Cao, Dongsun ^b,c   Wang, Qing ^d   Wang, Da Zhi ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; MYOCARDIN; MYOSIN; MYOSIN HEAVY CHAIN ALPHA; SERUM RESPONSE FACTOR; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR TBX5; NUCLEAR PROTEIN; T-BOX TRANSCRIPTION FACTOR 5; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; GENE ACTIVATION; GENE EXPRESSION; GENE MAPPING; GENE TARGETING; HEART DEVELOPMENT; HEART MUSCLE; HOLT ORAM SYNDROME; NONHUMAN; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; RAT; REPORTER GENE; SMOOTH MUSCLE; TRANSCRIPTION INITIATION; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOUSE; MUTATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CERCOPITHECUS AETHIOPS; COS CELLS; GENES, REPORTER; HUMANS; MICE; MUTATION; MYOCARDIUM; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; T-BOX DOMAIN PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 80052282066     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024242     Document Type: Article

References (45)

1. Olson EN, (2006) Gene regulatory networks in the evolution and development of the heart. Science 313: 1922-1927.
2. Srivastava D, (2006) Making or breaking the heart: from lineage determination to morphogenesis. Cell 126: 1037-1048.
3. Clark KL, Yutzey KE, Benson DW, (2006) Transcription factors and congenital heart defects. Annu Rev Physiol 68: 97-121.
4. Mori AD, Bruneau BG, (2004) TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol 19: 211-215.
5. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, et al. (1997) Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15: 30-35.
6. Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, et al. (1997) Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 15: 21-29.
7. Heinritz W, Shou L, Moschik A, Froster UG, (2005) The human TBX5 gene mutation database. Hum Mutat 26: 397.
8. Stennard FA, Harvey RP, (2005) T-box transcription factors and their roles in regulatory hierarchies in the developing heart. Development 132: 4897-4910.
9. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, et al. (2001) A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106: 709-721.
10. Ghosh TK, Packham EA, Bonser AJ, Robinson TE, Cross SJ, et al. (2001) Characterization of the TBX5 binding site and analysis of mutations that cause Holt-Oram syndrome. Hum Mol Genet 10: 1983-1994.
11. Liberatore CM, Searcy-Schrick RD, Yutzey KE, (2000) Ventricular expression of tbx5 inhibits normal heart chamber development. Dev Biol 223: 169-180.
12. Melnyk AR, Weiss L, Van Dyke DL, Jarvi P, (1981) Malformation syndrome of duplication 12q24.1 leads to qter. Am J Med Genet 10: 357-365.
13. Dixon JW, Costa T, Teshima IE, (1993) Mosaicism for duplication 12q (12q13-->q24.2) in a dysmorphic male infant. J Med Genet 30: 70-72.
14. Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, et al. (2001) Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 28: 276-280.
15. Moskowitz IP, Kim JB, Moore ML, Wolf CM, Peterson MA, et al. (2007) A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129: 1365-1376.
16. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, et al. (2003) GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447.
17. Ghosh TK, Song FF, Packham EA, Buxton S, Robinson TE, et al. (2009) Physical interaction between TBX5 and MEF2C is required for early heart development. Mol Cell Biol 29: 2205-2218.
18. Stennard FA, Costa MW, Elliott DA, Rankin S, Haast SJ, et al. (2003) Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol 262: 206-224.
19. Maitra M, Schluterman MK, Nichols HA, Richardson JA, Lo CW, et al. (2009) Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev Biol 326: 368-377.
20. Zhu Y, Gramolini AO, Walsh MA, Zhou YQ, Slorach C, et al. (2008) Tbx5-dependent pathway regulating diastolic function in congenital heart disease. Proc Natl Acad Sci U S A 105: 5519-5524.
21. Koshiba-Takeuchi K, Takeuchi JK, Arruda EP, Kathiriya IS, Mo R, et al. (2006) Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart. Nat Genet 38: 175-183.
22. Fan C, Liu M, Wang Q, (2003) Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome. J Biol Chem 278: 8780-8785.
23. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, et al. (2001) Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105: 851-862.
24. Wang DZ, Olson EN, (2004) Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr Opin Genet Dev 14: 558-566.
25. Pipes GC, Creemers EE, Olson EN, (2006) The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev 20: 1545-1556.
26. Li S, Wang DZ, Wang Z, Richardson JA, Olson EN, (2003) The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci U S A 100: 9366-9370.
27. Wang DZ, Li S, Hockemeyer D, Sutherland L, Wang Z, et al. (2002) Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci U S A 99: 14855-14860.
28. Li J, Zhu X, Chen M, Cheng L, Zhou D, et al. (2005) Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development. Proc Natl Acad Sci U S A 102: 8916-8921.
29. Oh J, Richardson JA, Olson EN, (2005) Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc Natl Acad Sci U S A 102: 15122-15127.
30. Sun Y, Boyd K, Xu W, Ma J, Jackson CW, et al. (2006) Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator of mammary gland function. Mol Cell Biol 26: 5809-5826.
31. Parmacek MS, (2007) Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ Res 100: 633-644.
32. Huang J, Min Lu M, Cheng L, Yuan LJ, Zhu X, et al. (2009) Myocardin is required for cardiomyocyte survival and maintenance of heart function. Proc Natl Acad Sci U S A 106: 18734-18739.
33. Oh J, Wang Z, Wang DZ, Lien CL, Xing W, et al. (2004) Target gene-specific modulation of myocardin activity by GATA transcription factors. Mol Cell Biol 24: 8519-8528.
34. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, et al. (2004) Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428: 185-189.
35. Cao D, Wang Z, Zhang CL, Oh J, Xing W, et al. (2005) Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol Cell Biol 25: 364-376.
36. Callis TE, Cao D, Wang DZ, (2005) Bone morphogenetic protein signaling modulates myocardin transactivation of cardiac genes. Circ Res 97: 992-1000.
37. Tang RH, Zheng XL, Callis TE, Stansfield WE, He J, et al. (2008) Myocardin inhibits cellular proliferation by inhibiting NF-kappaB(p65)-dependent cell cycle progression. Proc Natl Acad Sci U S A 105: 3362-3367.
38. Liu ZP, Wang Z, Yanagisawa H, Olson EN, (2005) Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev Cell 9: 261-270.
39. Chen J, Kitchen CM, Streb JW, Miano JM, (2002) Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol 34: 1345-1356.
40. Mori AD, Zhu Y, Vahora I, Nieman B, Koshiba-Takeuchi K, et al. (2006) Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev Biol 297: 566-586.
41. Bimber B, Dettman RW, Simon HG, (2007) Differential regulation of Tbx5 protein expression and sub-cellular localization during heart development. Dev Biol 302: 230-242.
42. Camarata T, Bimber B, Kulisz A, Chew TL, Yeung J, et al. (2006) LMP4 regulates Tbx5 protein subcellular localization and activity. J Cell Biol 174: 339-348.
43. Habets PE, Moorman AF, Clout DE, van Roon MA, Lingbeek M, et al. (2002) Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev 16: 1234-1246.
44. Brown DD, Martz SN, Binder O, Goetz SC, Price BM, et al. (2005) Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis. Development 132: 553-563.
45. Stennard FA, Costa MW, Lai D, Biben C, Furtado MB, et al. (2005) Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development 132: 2451-2462.